Skip to content

Corporate Milestones

2009

FEops is founded

2015

EUR 1.3 million received in Series A financing

2015

TAVIguide™ receives CE mark

2016

Rob Michiels appointed chairman of the board of directors

2017

FEops closes EUR 6 million Series B financing, led by Valiance, and joined by existing investors Capricorn and PMV.

2018

FEops elects Tom Fleming to its board of directors

2018

TAVIguide extends CE mark indications to bicuspid patients